Treatment & Management of Gastric Cancer
Newsletter Signup | Join Community | Cancer Types
Opdivo plus chemotherapy delays progression of advanced Gastric/Esophageal cancer better than chemotherapy
The anti-FGFR2b inhibitor Bemarituzumab appears to improve outcomes in advanced gastric and gastroesophageal cancer
Combination Chemotherapy Has Potential as Standard Treatment for Advanced Gastric Cancer
HER2 targeted therapy improves outcome of HER2-positive stomach cancer and patients should undergo HER2 testing
Immunotherapy TKI combination effective in advanced gastric cancer.
The Wnt/beta-catenin pathway is a cancer driving pathway that can be targeted by the novel precision medicine DKN-01.
CAR-T cell therapy appears to generate some responses in advanced gastric and pancreatic cancers.
Helicobacter Pylori bacterial infection associated gastric (stomach) cancer risk is reduced by antibiotic treatment.